Lung Resistance protein and multidrug resistance protein in non-small cell lung cancer and their clinical significance

Journal of International Medical Research

Volumn 39, Issue 5, 2011, Pages 1693-1700

  Chen, Z J ^a   Le, H B ^a   Zhang, Y K ^a   Qian, L Y ^b   Raja Sekhar, K ^a   Li, Wei Dong ^c  

^a Department of Thoracic Surgery ^*  (China)

^b Department of Dermatology   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Lung Resistance Protein; Multidrug Resistance Protein; Non Small Cell Lung Cancer

Indexed keywords

LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PROGNOSIS; PROTEIN FUNCTION; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION;

EID: 80155211531     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900511     Document Type: Article

References (21)

1. Molina JR, Yang P, Cassivi SD, et al: Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83: 584-594.
2. Okamoto T, Ichinose Y: Adjuvant chemotherapy for non-small cell lung cancer. Gan To Kagaku Ryoho 2006; 33: 1985-1990 [in Japanese, English abstract].
3. Monzo M, Rosell R, Taron M: Drug resistance in non-small cell lung cancer. Lung Cancer 2001; 34(suppl 2): S91-S94.
4. Young LC, Campling BG, Cole SP, et al: Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Clin Cancer Res 2001; 7: 1798-1804.
5. Young LC, Campling BG, Voskoglou-Nomikos T, et al: Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. Clin Cancer Res 1999; 5: 673-680.
6. Laurençot CM, Scheffer GL, Scheper RJ, et al: Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines. Int J Cancer 1997; 72: 1021-1026.
7. Berger W, Elbling L, Micksche M: Expression of the major vault protein LRP in human nonsmall-cell lung cancer cells: activation by shortterm exposure to antineoplastic drugs. Int J Cancer 2000; 88: 293-300.
8. Dingemans AM, van Ark-Otte J, van der Valk P, et al: Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues. Ann Oncology 1996; 7: 625-630.
9. Klunder JW, Komdeur R, Van Der Graaf WT, et al: Expression of multidrug resistanceassociated proteins in rhabdomyosarcomas before and after chemotherapy: the relationship between lung resistance-related protein (LRP) and differentiation. Hum Pathol 2003; 34: 150-155.
10. Canitrot Y, Bichat F, Cole SP, et al: Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapy. Cancer Lett 1998; 130: 133-141.
11. Lange C, Walther W, Schwabe H, et al: Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter. Biochem Biophys Res Commun 2000; 278: 125-133.
12. Volm M, Koomägi R, Mattern J, et al: Protein expression profiles indicative for drug resistance of non-small cell lung cancer. Br J Cancer 2002; 87: 251-257.
13. Meschini S, Marra M, Calcabrini A, et al: Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells. Toxicol In Vitro 2002; 16: 389-398.
14. Sun ZY, Yu HY, Liu HM, et al: Expression of multiple drug resistance-associated proteins in non-small cell lung cancer tissues and its clinical significance. Tumor 2007; 27: 303-307 [in Chinese].
15. Goldstein LJ, Galski H, Fojo A, et al: Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81: 116-124.
16. Yu W, Xiang F, Wang R, et al: The quantitative analysis of lung resistant protein in NSCLC and its clinical significance. Acta Academiae Medicinae Qingdao Universitatis 2007; 43: 64-66 [in Chinese].
17. Xu J, Zhou C, Yi X, et al: The expression of lung resistant protein and multi-drug resistance protein in NSCLC. Doctor Advanced Periodica (Medicine) 2004; 27: 41-42 [in Chinese].
18. Li X-Q, Li J, Chen P: Expression and clinical significance of MRP1 and LRP mRNA in nonsmall cell lung cancer. Practical J Cancer 2008; 23: 145-147 [in Chinese].
19. Yu SP, Xiong YY, Tian SF: Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma. Zhonghua Jie He He Hu Xi Za Zhi 2003; 26: 165-168 [in Chinese, English abstract].
20. Che C-I, Huo J-M: Clinical mean of expression of multi-drug resistance protein in non-small cell lung cancer. J Harbin Medical University 2006; 40: 309-311 [in Chinese].
21. Li J, Li ZN, Yu LC, et al: Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced nonsmall cell lung cancer who received neoadjuvant chemotherapy. Lung Cancer 2010; 69: 116-122.